The Gold Standard for Precision Brightening: 99%+ Ultra-Pure Tranexamic Acid

In the luxury dermocosmetic sector, formulators are caught between the demand for rapid, high-potency spot correction and the strict safety requirements of the modern consumer. Traditional brightening protocols often rely on hydroquinone-based combinations, which, while effective, carry high risks of post-inflammatory hyperpigmentation and severe skin irritation. Our 99%+ Ultra-Pure Tranexamic Acid is the clinical-grade breakthrough that eliminates this compromise. Engineered for total safety and high-speed efficacy, it empowers your brand to deliver “fast-action” brightening results that are scientifically validated to outperform the traditional “gold standard” combinations while reducing side-effect rates by more than half.

Unrivaled Efficacy: Clinical & Laboratory Proof

• Clinical Superiority vs. Hydroquinone: In independent clinical trials for chloasma (melasma) treatment, Tranexamic Acid demonstrated a MASI score reduction comparable to the hydroquinone + dexamethasone group (from 31.68 to 12.01 over 12 weeks), but with a significantly safer profile.

• Drastic Side-Effect Reduction: Clinical data reveals a side-effect rate of only 20% with Tranexamic Acid, compared to a 48% incidence rate in traditional hydroquinone/dexamethasone treatments.

• High-Speed Radiance: Clinically proven to accelerate complexion brightening and pigment reduction within 1-2 weeks of consistent application.

• Enzymatic Blockade: Directly inhibits the conversion of plasminogen to plasmin, effectively blocking the UV-induced PA system and preventing the inflammatory triggers of melanogenesis.

Core Specifications & Technical Parameters

パラメータ	仕様
純度（HPLC）	>= 99%
CAS番号	1197-18-8
外観	白色結晶性粉末
溶解性	高い水溶性
11. 熱可逆性オプション	Excellent (Not easily discolored)
推奨使用量	1.0% – 3.0% (Up to 5.0% for intensive care)
賞味期限	24ヶ月
保管方法	Store in a cool, dark, dry place

Formulation Intelligence: The “Golden Synergy” Blends

Accelerate your R&D pipeline with these strategically optimized pairings, designed for high-performance, clinical-grade results:

• The “Luminous Barrier” Complex: Combine with ナイアシンアミド. This synergy offers a dual-pathway approach: Tranexamic Acid blocks the inflammatory triggers of pigmentation, while Niacinamide inhibits melanosome transfer, creating a comprehensive “prevention + correction” system.

• The “Advanced Brightening” Serum: Pair with Vitamin C Derivatives. This combination maximizes antioxidant protection and surface-level brightening; the Tranexamic Acid mitigates potential irritation from the Vitamin C, ensuring maximum tolerance for sensitive skin.

• The “Melasma-Targeted” Spot Corrector: Integrate with アルファアルブチン. By combining two distinct enzymatic inhibitors, this formula provides a powerful solution for stubborn, localized hyperpigmentation and age spots.

Quality Assurance & Regulatory Excellence

Our production standards reflect the precision required by global dermatological brands, ensuring total supply chain confidence:

• ISO 9001

• ISO 22000

• COSMOS

• HALAL

• IQNET

Our comprehensive technical dossier—including TDS, MSDS, and COA—is available to support your regulatory and safety assessment requirements.

Secure Your Competitive Edge in Brightening Tech

True innovation in depigmentation requires a shift away from high-toxicity actives toward precision bioactives. Do not settle for outdated combinations that compromise your consumer’s safety. Integrate the high-purity, clinical reliability of our Tranexamic Acid into your next generation of brightening solutions.

Contact our technical advisory team today to secure your professional evaluation samples and gain immediate, priority access to our full library of technical validation reports and clinical efficacy data.

Request your technical dossier and premium-grade samples today to initiate the next generation of safe, high-speed brightening care.